98 related articles for article (PubMed ID: 16761016)
1. Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions.
Verheyden S; Demanet C
Leukemia; 2006 Aug; 20(8):1437-8. PubMed ID: 16761016
[No Abstract] [Full Text] [Related]
2. Hepatitis C virus and the threshold of natural killer cell inhibition.
Ahlenstiel G; Rehermann B
Hepatology; 2005 Mar; 41(3):675-7. PubMed ID: 15723330
[No Abstract] [Full Text] [Related]
3. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
[TBL] [Abstract][Full Text] [Related]
4. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
5. Role of a KIR/HLA-C allorecognition system in pregnancy.
Varla-Leftherioti M
J Reprod Immunol; 2004 Jun; 62(1-2):19-27. PubMed ID: 15288178
[TBL] [Abstract][Full Text] [Related]
6. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
9. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
Rajagopalan S; Winter CC; Wagtmann N; Long EO
J Immunol; 1995 Nov; 155(9):4143-6. PubMed ID: 7594568
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
11. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
[TBL] [Abstract][Full Text] [Related]
12. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
Le Bouteiller P; Barakonyi A; Giustiniani J; Lenfant F; Marie-Cardine A; Aguerre-Girr M; Rabot M; Hilgert I; Mami-Chouaib F; Tabiasco J; Boumsell L; Bensussan A
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16963-8. PubMed ID: 12486241
[TBL] [Abstract][Full Text] [Related]
13. Immunology. A perfect mismatch.
Kärre K
Science; 2002 Mar; 295(5562):2029-31. PubMed ID: 11896262
[No Abstract] [Full Text] [Related]
14. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
[TBL] [Abstract][Full Text] [Related]
16. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
Naumova E; Mihaylova A; Ivanova M; Mihailova S
Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
[TBL] [Abstract][Full Text] [Related]
17. HLA-G and its KIR ligands in cancer--another enigma yet to be solved?
Urosevic M; Trojan A; Dummer R
J Pathol; 2002 Mar; 196(3):252-3. PubMed ID: 11857486
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
19. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
[TBL] [Abstract][Full Text] [Related]
20. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.
Rojo S; Wagtmann N; Long EO
Eur J Immunol; 1997 Feb; 27(2):568-71. PubMed ID: 9045932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
